VULVAR CANCER WITH POSITIVE NODES OF THE GROIN - PELVIC LYMPHADENECTOMY, ADJUVANT RADIOTHERAPY OR RADIOCHEMOTHERAPY?

ESGO eAcademy, Sven Mahner, 39124

ISOLATED TUMOUR CELLS AND MICROMETASTASES: HOW TO DEAL WITH IT?

ESGO eAcademy, Nadeem Abu Rustum, 39125

PITFALLS IN SENTINEL NODE DETECTION IN VULVAR CANCER: AN IN DEPTH ANALYSIS OF FALSE NEGATIVE CASES

ESGO eAcademy, Maaike Oonk, 39126

QUALITY OF LIFE AND SURVIVAL AFTER SN BIOPSY. RESULTS OF THE SENTICOL II, RANDOMIZED TRIAL

ESGO eAcademy, Patrice Mathevet, 39127

ENDOMETRIAL CANCER: PREOPERATIVE ULTRASOUND ASSESSMENT TO TAILOR SURGERY

ESGO eAcademy, Elisabeth Epstein, 39118

NEW IMAGING TECHNOLOGY IN OVARIAN CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39119

ULTRASOUND VERSUS MRI IN CERVICAL CANCER STAGING AND INDIVIDUAL TREATMENT PLANNING

ESGO eAcademy, Daniela Fischerova, 39120

IMAGING PRE-INVASIVE TUBAL LESIONS IN HIGH RISK POPULATIONS

ESGO eAcademy, Jessica McAlpine, 39112

TUBAL PATHOLOGY IN BRCA 1 AND 2 MUTATION CARRIERS

ESGO eAcademy, Ronny Drapkin, 39114

CONTROVERSIES IN ADJUVANT THERAPY

ESGO eAcademy, Wui-Jin Koh, 39115

CONTROVERSIES IN THE MANAGEMENT OF ADVANCED CASES IN VULVAR CANCER

ESGO eAcademy, Lukas Rob, 39116

CURRENT STATUS OF SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39117

IMPLICATIONS FOR FUTURE RESEARCH

ESGO eAcademy, Ignance Vergote, 39341

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - US VIEW

ESGO eAcademy, Sean C. Dowdy, 39339

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - EUROPEAN VIEW

ESGO eAcademy, Nicoletta Colombo, 39338

COMPLICATIONS AND MORTALITY ASSOCIATED WITH PRIMARY OPTIMAL CYTOREDUCTION

ESGO eAcademy, Angelo Maggioni, 39109

NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER

ESGO eAcademy, Ignance Vergote, 39110

PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER

ESGO eAcademy, Giovanni Scambia, 39111

GUIDELINES AND LEVEL OF EVIDENCE FROM THE TRIALS

ESGO eAcademy, John A Green, 39105

Treatment-Surgery-Lymph Nodes- Radiotherapy- Chemotherapy- Individualization- Recurrence

ESGO eAcademy, Paolo Zola, 39106

WHAT IS ENDOMETRIAL CANCER - PATHOLOGY, MOLECULAR CHARACTERISATION ETC, EPIDEMIOLOGY

ESGO eAcademy, Glenn McCluggage, 39108

IS THE THERAPY-FREE INTERVAL OF 6 MONTHS STILL A USEFUL MODEL FOR GUIDING 2NDLINE OR HIGHER THERAPIES IN OVARIAN CANCER?

ESGO eAcademy, Daniel U. Reimer, 39100

TREATMENT CONSIDERATIONS IN CERVICAL CANCER WITH PELVIC RECURRENCE AFTER ADJUVANT OR PRIMARY RADIOCHEMOTHERAPY

ESGO eAcademy, Stefano Greggi, 39101

TREATMENT CONSIDERATIONS IN PATIENTS WITH RECURRENT CARCINOMATOSIS AFTER SEVERAL LINES OF CHEMOTHERAPY AND SUBILEUS/ILEUS

ESGO eAcademy, Philipp Harter, 39102

TREATMENT CONSIDERATIONS IN VULVA CARCINOMA WITH LOCO-REGIONAL RECURRENCE

ESGO eAcademy, Ate G.J. van der Zee, 39103

PROGRESS IN RISK PREDICTION, DIAGNOSIS AND SCREENING FOR OVARIAN CANCER

ESGO eAcademy, Ian Jacobs, 39099

Vaginal Trachelectomy + Laparoscopic LND

ESGO eAcademy, Achim Schneider, 39134

Surgical Staging of Cervical Carcinoma and Extraperitoneal LND

ESGO eAcademy, Eric Leblanc, 39135

ROBOTIC SURGERY FOR THE MANAGEMENT OF CERVICAL CANCER

ESGO eAcademy, Angelo Maggioni, 39136

Vulva Cancer: VFR and Recostruction with Flaps

ESGO eAcademy, Nadja Dornhöfer, 39138

SLN in Vulvar Cancer

ESGO eAcademy, Ate G.J. van der Zee, 39139

PALLIATIVE AND END OF LIFE CARE IN GYNECOLOGICAL CANCER - GOING BEYOND THE PHYSICAL

ESGO eAcademy, Mari Lloyd-Williams, 39097

PALLIATIVE CARE - END OF LIFE CARE IN GYNECOLOGICAL CANCER : ASPECTS OF CLINICAL PRACTICE

ESGO eAcademy, Johan Menten, 39098

Cancer: A Family Affair

ESGO eAcademy, Lea Baider, 48149

Anxiety and Adjustment Disorders in Cancer Patients

ESGO eAcademy, Katalin Muszbek, 48150

Loss, Grief and Bereavement

ESGO eAcademy, David Kissane, 48151

Palliative Care for the Psycho-Oncologist

ESGO eAcademy, William Breitbart, 48152

Ethical Implications of Psycho-Oncology

ESGO eAcademy, Antonella Surbone, 48153

Psychosocial Interventions: Evidence and Methods for Supporting Cancer Patients

ESGO eAcademy, Maggie Watson & Barry Bultz, 48154

Psychosocial Assessment in Cancer Patients

ESGO eAcademy, Uwe Koch & Anja Mehnert, 48155

Communication and Interpersonal Skills in Cancer Care

ESGO eAcademy, Walter F. Baile, 48156

Distress Management in Cancer

ESGO eAcademy, Jimmie C. Holland, 48157

Depression and Depressive Disorders in Cancer Patients

ESGO eAcademy, Luigi Grassi & Yosuke Uchitomi, 48158

Guideliness and Evidence from the Trials about Follow up

ESGO eAcademy, Elisa Piovano, 45901

PERSONALIZED SURGICAL CARE FOR CERVICAL CANCER

ESGO eAcademy, Rene H.M. Verheijen, 39091

SENTINEL NODE CONCEPT AND RELEVANCE OF DETECTION OF MICROMETASTASES

ESGO eAcademy, David Cibula, 39092

(NEO-) ADJUVANT CHEMOTHERAPY AND CERVICAL CANCER

ESGO eAcademy, Roberto Angioli, 39093

NO HEALTH WITHOUT MENTAL HEALTH: THE IMPORTANCE OF PSYCHOSOCIAL CARE IN GYNAECOLOGICAL CANCER

ESGO eAcademy, Maggie Watson, 39083

PHYSICAL ACTIVITY AFTER CANCER

ESGO eAcademy, Freerk T. Baumann, 39084

POPULATION BASED OUTCOMES OF EARLY STAGE OVARIAN ENDOMETRIOID CARCINOMA (OEC) IN BRITISH COLUMBIA

ESGO eAcademy, Aalok Kumar, 39086

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF WEEKLY PACLITAXEL PLUS TREBANANIB OR PLACEBO IN WOMEN WITH RECURRENT OVARIAN CANCER: TRINOVA-1

ESGO eAcademy, Bradley Monk, 39087

ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER

ESGO eAcademy, Eric Pujade-Lauraine, 39088

RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.

ESGO eAcademy, Fharat Raja, 39089

PELVIC LYMPHADENECTOMY IMPROVES SURVIVAL IN CERVICAL CANCER PATIENTS WITH LOW VOLUME DISEASE IN THE SENTINEL NODE, A RETROSPECTIVE MULTICENTRE COHORT STUDY

ESGO eAcademy, Afra Zaal, 39090

Principles of Total Omentectomy

ESGO eAcademy, Di Donato Violante, 39128

Splenectomy and Distal Pancreatectomy in Ovarian Cancer

ESGO eAcademy, Eric Leblanc, 39129

Staging Lymphadenectomy

ESGO eAcademy, Andreas Widschwendter, 39130

Modified Posterior Exenteration

ESGO eAcademy, David Cibula, 39131

Liver Mobilization and Diaphragm Peritonectomy

ESGO eAcademy, Nadeem Abu Rustum, 39132

ROBOTIC STAGING

ESGO eAcademy, K. Rainer Kimmig, 39133

HPV SELF-SAMPLING

ESGO eAcademy, Paolo Giorgi Rossi, 39077

HPV TESTING IN PRIMARY SCREENING IN LOW RESOURCES SETTINGS

ESGO eAcademy, Maribel Almonte, 39078

HPV TESTING/GENOTYPING IN PRIMARY SCREENING IN DEVELOPED COUNTRIES

ESGO eAcademy, Mario Sideri, 39079

ADAPTIVE BRACHYTHERAPY AND BEYOND IN CERVICAL CANCER TREATMENT

ESGO eAcademy, Christine Haie-Meder, 39073

LOCO REGIONAL RECURRENCES IN GYNECOLOGICAL MALIGNANCIES : TREATMENT COMPLICATIONS AND COST ANALYSIS

ESGO eAcademy, Alessandro Urgesi, 39074

HEALTH AND WELLBEING IN WOMEN

ESGO eAcademy, Peter Kinderman, 39075

PATIENT AND CLINICIAN PERSPECTIVES: A MEDICAL HUMANITIES VIEW OF THE CONSULTATION IN GYNAE ONCOLOGY.

ESGO eAcademy, Jane Macnaughton, 39076

FUNCTIONAL MR AS A BIOMARKER OF RESPONSE TO TREATMENT IN LOCALLY ADVANCED CERVICAL CANCER

ESGO eAcademy, Margaret Hall-Craggs, 45897

1ST LINE TREATMENT (SURGERY AND SYSTEMIC THERAPY) - STATE OF THE ART 2013

ESGO eAcademy, Christian Marth, 39070

PLATINUM SENSITIVE RELAPSE: THE ROLE OF SURGERY AND CURRENT STATE OF THE ART OF SYSTEMIC THERAPY

ESGO eAcademy, Philipp Harter, 39071

STATE-OF-THE ART AND NEW OPTIONS IN THE TREATMENT OF RELAPSE WITHIN A YEAR AFTER 1STLINE

ESGO eAcademy, Domenica Lorusso, 39072

PERSONALIZED THERAPY IN GYNAECOLOGIC ONCOLOGY: BIOLOGY, STRATEGY, AND ASSESSMENT

ESGO eAcademy, Anil Sood, 39064

PERSPECTIVES ON RECEPTOR TYROSINE KINASE ACTIVATION IN OVARIAN CANCER AND ITS RELATIONSHIP TO PERSONALISED MEDICINE

ESGO eAcademy, Hani Gabra, 39065

EUTHANASIA

ESGO eAcademy, Johan Menten, 39066

HARMONIZATION OF RADICAL HYSTERECTOMY CLASSIFICATION

ESGO eAcademy, David Cibula, 39067

HIPEC ROLE IN OVARIAN CANCER

ESGO eAcademy, Anna Fagotti, 39068

MANAGEMENT OF LOCALLY ADVANCED CERVICAL CANCER

ESGO eAcademy, Denis Querleu, 39069

PHASE III TRIAL OF EVERY-3-WEEKS PACLITAXEL VS. DOSE DENSE WEEKLY PACLITAXEL WITH CARBOPLATIN +/- BEVACIZUMAB IN EPITHELIAL OVARIAN, PERITONEAL, FALLOPIAN TUBE CANCER: GOG 262 (NCT01167712)

ESGO eAcademy, JOHN CHAN, 39058

AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL OF STANDARD FRONTLINE CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER

ESGO eAcademy, Andreas Du Bois, 39059

PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF WEEKLY FARLETUZUMAB WITH CARBOPLATIN/TAXANE IN SUBJECTS WITH PLATINUM-SENSITIVE OVARIAN CANCER IN FIRST RELAPSE

ESGO eAcademy, Ignance Vergote, 39061

Robotic Surgery in Gynaecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module I: Common Iliac, Subaortic and Presacral Nodes

ESGO eAcademy, K. Rainer Kimmig, 38736

Robotic Surgery in Gynecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module III: Upper Paravisceral - Prespinal and Preischaidic Nodes

ESGO eAcademy, K. Rainer Kimmig, 38738

Robotic Surgery in Gynaecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module II: Lower Paravisceral and External Iliac Nodes

ESGO eAcademy, K. Rainer Kimmig, 38737

Debulking Procedures - Splenectomy with Total Omentectomy

ESGO eAcademy, David Cibula, 50935

Debulking Procedures - Liver Mobilisation and Diaphragm Stripping

ESGO eAcademy, David Cibula, 50936

Designing Clinical Trials with Patient - Reported Outcomes as Trials Endpoits

ESGO eAcademy, Eva Greimel, 34943

When and How Should Patient- Reported Outcome be Measured and Incorporated into Clinical Trials

ESGO eAcademy, Felix Hilpert, 34948

GYN Translational Research Organisation in Europe

ESGO eAcademy, MICHAEL BIRRER, 34944

What is EUTROC?

ESGO eAcademy, Jalid Sehouli, 34946

What is ENGOT?

ESGO eAcademy, Andreas Du Bois, 34941

What is GCIG?

ESGO eAcademy, Eric Pujade-Lauraine, 34942

Sum-Up of Visions and Missions

ESGO eAcademy, Karina Dahl Steffensen, 34940

Robot-Assisted Laparoscopic Nerve Sparing - Okabayashi's Radical Hysterectomy according to Shingo Fujii's Technique

ESGO eAcademy, Angelo Maggioni, 33613

Easy Learning Hysterectomy - Panniculectomy to Facilitate Abdominal Hysterectomy and Staging

ESGO eAcademy, N. R. Abu-Rustum & B. Mehrara, 33612

Abdominal Procedures in Gynaecological Oncology - Extrafascial Hysterectomy

ESGO eAcademy, David Cibula & Tomas Herrmann, 33611

Robotic Surgery in Gynaecology - Therapeutic Paraaortic Lymphadenectomy (TPL2) - Module V1: Infrarenal/Supramesenteric Periaortic Nodes

ESGO eAcademy, K. Rainer Kimmig, 95405

Closed and Published Trials - Cervical Cancer

ESGO eAcademy, Bradley Monk, 41673

An Introduction to Patient Reported Outcomes in Clinical Trials

ESGO eAcademy, Antonio Gonzalez, 41672

Closed and Published Trials - Ovarian Cancer

ESGO eAcademy, Bradley Monk, 41674

ASCO/ESMO/IGCS 2012 Pivotal Data Critique. How These Data Impact the State of the Art

ESGO eAcademy, Nicoletta Colombo, 42271